Proteomics International Partners With University of Oxford to Advance Endometriosis Study

Predictive diagnostics specialist Proteomics International Laboratories (ASX: PIQ) has signed an agreement with the University of Oxford to acquire approximately 600 patient plasma samples for a study into endometriosis.

Small CapsMar 25 08:13

Proteomics International Signs Agreement With University of Oxford for Endometriosis Study

Proteomics International Laboratories (ASX:PIQ) has partnered with the University of Oxford to acquire approximately 600 patient plasma samples for further clinical validation of its PromarkerEndo blo

MT NewswiresMar 25 07:50

Proteomics Says PromarkerD's US Launch Delayed

Proteomics International Laboratories (ASX:PIQ) said the US roll out of its PromarkerD predictive test for diabetic kidney disease, originally planned for Q2 of 2024, is now "likely to be delayed," ac

MT NewswiresMar 19 17:23

Proteomics International Laboratories Downgraded to Hold From Speculative Buy by Morgans

Proteomics International Laboratories Downgraded to Hold From Speculative Buy by Morgans

Dow JonesMar 12 09:34

Proteomics International Laboratories Secures ISO 13485 Certification Renewal

Medical technology company Proteomics International Laboratories (ASX:PIQ) secured ISO 13485 recertification, which is valid for three years, according to a filing with the Australian Securities Excha

MT NewswiresMar 6 11:41

Proteomics International Laboratories Narrows Fiscal H1 Loss

Proteomics International Laboratories (ASX:PIQ) reported Friday a net loss of AU$3.8 million in the six months ended Dec. 31, 2023, narrowing from AU$4.0 million a year earlier. Loss per share remaine

MT NewswiresFeb 23 18:27